In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Discovery Partners and Infinity merge

Executive Summary

Public drug discovery services company Discovery Partners International (DPI) and Infinity Pharmaceuticals (small-molecule cancer therapeutics) have merged to form a new entity under the Infinity name that will be focused on cancer drug discovery and development.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Services
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Contract
    • Reverse Acquisition
    • Payment Includes Stock
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register